BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16194712)

  • 21. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
    Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
    J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
    Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R
    Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retropubic versus perineal radical prostatectomy in early prostate cancer: eight-year experience.
    Martis G; Diana M; Ombres M; Cardi A; Mastrangeli R; Mastrangeli B
    J Surg Oncol; 2007 May; 95(6):513-8. PubMed ID: 17226809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radical perineal prostatectomy--surgical technique, first results].
    Mshvildadze ShT; Udzhmadzhuridze AN; Managadze GL; Shtakl' V
    Georgian Med News; 2007 Feb; (143):58-63. PubMed ID: 17404442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
    BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of the urinary status by self-administered questionnaires in men after radical prostatectomy-- comparison with the urination status of elderly women].
    Taoka R; Shimada O; Kitamura Y; Okazoe H; Taniguchi S; Tsunemori H; Wu X; Inui M; Sugimoto M; Kakehi Y
    Hinyokika Kiyo; 2008 Nov; 54(11):717-22. PubMed ID: 19068725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Operative details and oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: 400 cases with a minimum of 12 months follow-up.
    Murphy DG; Kerger M; Crowe H; Peters JS; Costello AJ
    Eur Urol; 2009 Jun; 55(6):1358-66. PubMed ID: 19147274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
    Secin FP; Bianco FJ; Vickers AJ; Reuter V; Wheeler T; Fearn PA; Eastham JA; Scardino PT
    Cancer; 2006 Jun; 106(11):2369-75. PubMed ID: 16649221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.
    Loeb S; Smith ND; Roehl KA; Catalona WJ
    Urology; 2007 Jun; 69(6):1170-5. PubMed ID: 17572209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined radical prostatectomy and bladder augmentation for concomitant prostate cancer and detrusor instability.
    Quek ML; Barry P; Stein JP; Lieskovsky G; Ginsberg DA
    Urology; 2005 May; 65(5):964-7. PubMed ID: 15882732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy.
    Sengupta S; Myers RP; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
    J Urol; 2005 Dec; 174(6):2191-6. PubMed ID: 16280762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance.
    Sengupta S; Christensen CM; Zincke H; Slezak JM; Leibovich BC; Bergstralh EJ; Myers RP; Blute ML
    J Urol; 2006 Aug; 176(2):559-63. PubMed ID: 16813889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of sexual function and sexual bother following autologous sural nerve grafting during radical prostatectomy.
    Kuwata Y; Muneuchi G; Igawa HH; Tsukuda F; Inui M; Kakehi Y
    Int J Urol; 2007 Jun; 14(6):510-4. PubMed ID: 17593095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
    Pfitzenmaier J; Pahernik S; Tremmel T; Haferkamp A; Buse S; Hohenfellner M
    BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy.
    Hong SK; Han BK; Jeong SJ; Byun SS; Lee SE
    J Urol; 2007 Aug; 178(2):613-6. PubMed ID: 17570410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.